A Clinical Trial to Evaluate the Efficacy of Uppu Mezhugu in the Management of Vatha Gunmam (Peptic Ulcer Disease)

A Prospective Open labelled, Single arm, Non-randomized, Single centric,Phase II, Clinical trial to determine the effectiveness of Uppu mezhugu in the management of Vatha gunmam (Peptic Ulcer Disease). - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105553

Enrollment

Registered

2026-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation

Interventions

Intervention1: UPPU MEZHUGU: Dosage: 488 mg twice a day orally for 21 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patient having Symptoms of Abdominal Pain Constipation Vomiting Indigestion Fatigue & Weakness Body Pain Headache Dizziness Patient who are willing to take Upper Gastro Intestinal Endoscopy

Exclusion criteria

Exclusion criteria: CA Stomach Hypertension Liver Disorder Any acute illness such as Cholelithiasis, Acute Pancreatitis Cardiac diseases Appendicitis Renal Disorders Pregnancy & Lactation Dyspnea & Bronchial Asthma

Design outcomes

Primary

Measure	Time frame
The outcome will be aimed at reducing the clinical symptoms of Vatha Gunmam (Peptic Ulcer Disease) and to prevent the recurrence of the disease by advising, continuous and periodic intake of medicine and dietary regimen.Timepoint: 21 Days	—

Secondary

Measure	Time frame
Evalution of additional effects and siddha parametric changes in vatha gunmam.Timepoint: 21 Days	—

Countries

India

Contacts

Public ContactDr S JUSTUS ANTONY

Government Siddha Medical College and Hospital, Palayamkottai, Tirunelveli.

justusantony71@gmail.com9443090849

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026